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A monoclonal antibody (MB-19) was used to investigate the polymorphism of apolipoprotein B in a large 
family and in unrelated subjects. Apohpoprotein B was shown to exhibit high-, intermediate- or low-affinity 
binding to this antibody. Thus, MB-19 bound strongly to the Ag(c) epitope, an Ag antigenic domain pre- 
viously characterized by human antisera, while it bound only weakly to the allelic epitope Ag(g). It proved 
therefore useful for the detection of the two corresponding allelic apoB species designated apoB, (high-affin- 
ity binding) and apoB, (low-affinity binding), and for confirming their co-dominant transmission. Interme- 
diate binding resulted from the presence of a mixture of both apoB populations in heterozygous ubjects. 
Ag polymorphism Apolipoprotein B LDL Monoclonal anti-apoB antibody ApoB polymorphism 
1. INTRODUCTION 
The genetic variation in human low-density 
lipoprotein (Ag polymorphism) was discovered us- 
ing antisera obtained from multiply transfused pa- 
tients [l]. Subsequently, 5 pairs of Ag antigens 
behaving as products of allelic genes were defined 
[2,3] and located in apolipoprotein B (apoB) 141. 
The existence of polymorphic species of apoB is of 
interest because this apoprotein is recognized by 
the low-density lipoprotein (LDL) receptor. 
Using previously characterized monoclonal an- 
tibodies [5,6] Schumaker et al. [7] described a com- 
mon apoB polymorphism. This initial report was 
based on a semiquantitative method, which may 
have resulted in misclassification of some LDL 
samples, as pointed out by Young et al. [S], and 
therefore to the conclusion that the polymorphism 
was not related to the Ag system (71. Using one of 
the antibodies (MB-19) we explored the matter fur- 
ther. We now report that the Ag antigenic deter- 
minants Ag(c) and Ag(g) can be distinguished us- 
ing this antibody. Moreover, the co-dominant in- 
heritance of two allelomorphic apoB species, 
designated apoB, and apoB,, was confirmed. 
2. MATERIALS AND METHODS 
2.1. Subjects 
The Ag phenotypes as well as the reactivity of 
apoB with antibody MB-19 were studied in an East 
Finnish family with hypercholesterolemia, nd in a 
group of healthy unrelated individuals. 
2.2. LDL 
LDL (density 1.019-l .050 g/ml) was isolated by 
sequential ultracentrifugation [9] and its apoB con- 
tent (LDL-apoB) determined using a conventional 
anti-apoB antiserum (Orion Diagnostica, Hel- 
sinki). 
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2.3. Ag phenotyping 
The determination of Ag antigenic determinants 
was carried out by a passive hemagglutination in- 
hibition method [lo] using human antisera against 
the Ag factors x, y, al, d, c, g, t, z and h. 
2.4. The enzyme-linked immunosorbent 
displacement assay (ELBA) =/a, 
The reactivity of apoB-containing LDL with an- 
tibody MB-19 was assessed by ELISA as follows 
(fig.1). Flat-bottomed microtitration plates (Flow 
Laboratories, CT) were coated with 200~1 stan- 
dard LDL (1 pg/ml in PBS) by incubation for 4 h 
at 23°C. After saturating the extra binding sites 
with 3% bovine serum albumin (BSA) for 2 h at 
23°C the wells received 50 pl of a 1: 15 000 dilution 
of ascites fluid containing antibody MB-19 [5,8] 
and increasing amounts of LDL-apoB BSA-PBS 
(150 ~1) as indicated on the abscissa in fig. 1. After 
incubation (4 h, 23”C), wells were rinsed 3 times 
with 1% BSA-PBS, followed by addition of a 
1: 500 dilution in 1% BSA-PBS of alkaline 
phosphatase-conjugated anti-mouse IgG (Orion 
Diagnostica, Finland). Following incubation with 
this second antibody (3 h, 23”C), and subsequent 
rinsing with 1% BSA-PBS, 0.2% disodium p- 
nitrophenyl phosphate was added to each well. The 
reaction was stopped after 30 min by 1 N NaOH. 
The microtitration plates were read at 405 nm us- 
ing a Titertek MultiskanR eight-channel photo- 
meter (Eflab Oy, Helsinki). 
F&l. The reactivity of apoB with antibody MB-19 in 
the family of the proposita (no. 12 in family E shown in 
fig.2). Displacement curves were produced by LDL- 
apoB obtained from the father (=), mother = proposita 
(0), daughter (0) and son (0). The results of 
competition ELISA are expressed as B/go, where B 
denotes absorbance in the presence and BO in the absence 
of competing apoB (contained in LDL). For 
comparison, the displacement abilities of apoB from a 
group of unrelated subjects are shown: the vertical bars 
indicate mean + SD for different LDL or plasma 
samples obtained from subjects with weak (n = lo), 
intermediate (n = 10) and strong (n = 10) binding 
1 7 
ape-6 ( pg/ml) 
activities determined using 6.25 pg/ml of apoB. 
J? t 
A B C D E 
Fig.2. Transmission of apoB immunophenotypes in an East Finnish family. (0, 0) High-affinity binding, (0, q ) 
intermediate-affinity binding, (0, n ) low-affinity binding. Arrows indicate subjects with elevated serum cholesterol 
levels. Lipid analytic data will be reported in detail elsewhere. 
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3. RESULTS 
The competitive displacement assays with an- 
tibody MB-19 demonstrated that LDL-apoB ex- 
hibited high-, intermediate- or low-affinity binding 
to this antibody (fig.1). The inheritance of apoB 
reactivity was investigated in a large family (fig.2). 
The 9 high-affinity reactors displayed an average 
B/Be of 0.30 it 0.02 (mean + SD), the 17 in- 
termediate reactors had an average of 0.45 f 0.04, 
and the corresponding value for the 4 low-affinity 
reactors was 0.91 + 0.06. Comparison with the 
corresponding Ag antigen phenotypes revealed 
that the 9 high-affinity binders were all 
Ag(c+g-), whereas the 4 low-affinity binders 
were Ag(c-g +) (table 1). Moreover, all the 17 
intermediate-affinity binders were Ag(c + g + ). 
Consistent results were obtained when the Ag 
phenotypes and antibody MB-19 binding data 
from 20 unrelated individuals were compared 
(table 1). This striking relationship suggests that 
antibody MB-19 is an anti-Ag(c) reacting strongly 
with the apoB carrying the Ag(c) domain (apoB,) 
but weakly with the apoB species containing the 
Ag(g) domain (apoB,). 
Table 1 
Expression of Ag phenotypes and apoB reactivity with antibody MB-19 
in families and unrelated individuals 
No.~ Ag phenotypes ApoB binding 
- 
Family A MO 
Fa 
Family B MO 
Fa 
Family E Mo 
Fa 
to MB-19 
xY aid tz hi cg 
4 -+ -+ +- -+ t-t I 
5 -+ ++ +- -+ -I-+ I 
14 -I- -+ f- -+ +- I-I 
IS -+ -+ +- -+ +- H 
16 --+ C-k +- -i- ++ I 
17 --+ +-t +-- -+ ++ I 
I8 --I- ++ f- ---i- ++ I 
19 -+ ++ +- -+ --t L 
6 ++ ++ +- -+ -+ L 
7 -+ ++ +- -+ ++ I 
20 -+ -+ +- -t +t 1 
21 -+ -+ +- -+ +-I- I 
22 -+ ++ +- -+ -“I- L 
8 -+ ++ i-- -+ ++ I 
9 -+ ++ +- -+ ++ I 
23 -+ -+ +- -+ +- H 
24 -+ -+ f- -+ +- H 
10 -+ -t+ +- -i- ++ I 
11 -+ ++ ++ -+ ++ I 
2.5 -+ -+ +- -+ +- H 
26 -+ -+ +- -+ +- H 
27 -+ -+ +-- -+ f- H 
28 -+ i-+ i-- -+ ++ I 
12 -+ --f f- -+ +- H 
13 -+ -+ +- -+ -+ L 
29 --+ -+ f- -+ ++ I 
30 -+ -+ +- -+ ++ I 
Family C MO 
Fa 
Family D MO 
Fa 
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4. DISCUSSION 
The present results indicate that antibody MB-19 
detects the Ag(c/g) polymorphism of apoB 
previously characterized by human antisera [2]. 
Without a single exception, individuals 
homozygous for the Ag(c) allele expressed high- 
affinity binding apoB, and those homozygous for 
the Ag(g) allele expressed low-affinity binding 
apoB. Moreover, apoB from individuals 
heterozygous for the Ag alleles c and g always ex- 
hibited intermediate binding (table 1). Thus, high- 
affinity binding to MB-19 corresponds to the 
presence of apoB,, low-affinity binding to the 
presence of apoBe, whereas intermediate binding 
reflects the presence of both apoB, and apoB,. 
This notion is supported by the data of Young et 
al. [8] who by Scatchard analyses demonstrated 
that the intermediate binding pattern results from 
a mixture of high- and low-affinity binding apoB. 
There is no evidence that any of the other Ag an- 
tigens would modify apoB binding to antibody 
MB-19. For example, in family E (table 1) the Ag 
antigens x, y, al, d, t, z, h and i were identical in 
all 4 family members while only c and g varied, 
demonstrating that only the c/g antigenic pair 
could contribute to binding differences in this 
instance. 
The apoB species with high- and low-affinity 
binding properties behave as products of two 
allelic genes which are expressed in an autosomal 
co-dominant fashion. For example, in family A 
Table 1 (continued) 
Other family 
members 1 -+ ++ +- -+ ++ 
2 -+ ++ ++ -+ +- 
3 -+ ++ +- -+ ++ 
Unrelated individuals: 
Strong binders 
Intermediate 
binders 
Weak binders 
1 -+ +- +- -+ +- 
2 -+ -+ +- -+ +- 
3 -+ ++ ++ -+ ++ 
4 -+ -+ +- -+ ++ 
5 -+ -+ +- -+ ++ 
6 ++ ++ +- +? ++ 
7 ++ ++ +- -+ ++ 
8 -+ f- ++ -+ ++ 
9 -+ -+ +- -+ ++ 
10 ++ ++ +- -+ ++ 
11 ++ +- +- -+ -+ 
12 -+ -+ +- -+ -+ 
13 ++ +- ++ -+ -+ 
14 ++ +- +- -+ -+ 
15 -+ -+ +- -+ -+ 
16 ++ ++ +- -+ -+ 
17 +- f- +- -+ -+ 
18 ++ +- +- -+ -+ 
19 ++ +- ++ -+ -+ 
20 ++ +- ++ -+ -+ 
I 
H 
I 
H 
H 
I 
I 
I 
I 
I 
I 
I 
I 
L 
L 
L 
L 
L 
L 
L 
L 
L 
L 
a Numbers refer to the pedigree shown in fig.2 
MO, mother; Fa, father; H, high-; I, intermediate-; L, low-affinity 
binding of apoB to antibody MB-19 
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(table 1, fig.21 father and mother exhibit in- 
termediate binding, two of the children express 
strong, three intermediate, and one weak binding. 
This approaches the ~ende~~an ratio of 1: 2 : 1, and 
the findings in other members of the pedigree 
shown in fig,2 also are compatible with this mode 
of inheritance. 
The data in table 1 and from other analyses (not 
shown) demonstrate that about 50% of unrelated 
subjects studied show the low-affinity binding pat- 
tern, 4O@i’o exhibit intermediate binding, and 10% 
h~8h-affi~l~ty binding. This indicates a gene fre- 
quency of about 0.70 for the more common allele 
(coding for apoB,, or how-affinity binding apoB) 
in unrelated individuals. This is the same as the fre- 
quency previously reported for the Ag(g) gene in 
the Swiss population f2]. Previously, Young et al. 
[S] reported that in California subjects the low- 
affinity binding pattern with MB-19 was the 
prevalent one (40%). These findings, both with 
regard to distribution of immunophenotypes and 
association with Ag system, differ from a previous 
report [s’] presumably because of different 
methodology. 
On the basis that MB-19 does not bind to the 
cefluiar binding site on apoB [I 13 it can be assumed 
that the A&c/g) allehc variation does not directly 
affect the LDL receptor recognition domain. This 
is supported by the finding that monoclonal an- 
tibodies directed against this domain [11-13) do 
not detect any polymorphisms of apoB [11,14]. 
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